The Native Antigen Company has announced the release of a native antigen preparation to help make diagnostic testing for human Metapneumovirus (hMPV) faster, more sensitive and more specific.
First isolated in 2001, hMPV is an important cause of community-acquired acute respiratory infection.
Serious illness may occur in the very young and in those who are chronically ill or immunosuppressed.
The identification of hMPV infection has predominantly relied on real-time PCR which can be time consuming and costly.
The new availability of this native antigen provides the in-vitro diagnostic manufacturer with the opportunity to develop cost-effective test kits based rapid lateral flow and ELISA formats.
